IMMUNOTHERAPY-IMMUNOMODULATION NLM AIDSLINE Important note: Information in this article was accurate in 1983. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


IMMUNOTHERAPY-IMMUNOMODULATION

JAMA; 248(20):2759-2772 1982. Unique Identifier : AIDSLINE ICDB/83601511
Patterson R; Norman P; Van Metre T; Northwestern Univ. Medical Sch., Chicago, IL

Abstract: Immunotherapy-immunomodulation is discussed with respect to inhalant allergen immunotherapy, immunotherapy for infectious diseases, transfer factor, and nonspecific immunotherapy. The latter is discussed with respect to BCG, Corynebacterium parvum, levamisole, thymosin, interferon, bone marrow replacement, and plasmapheresis. Results of bone marrow transplantation in patients with severe combined immunodeficiency, aplastic anemia, and malignant diseases are reviewed. (32 Refs)
Keywords: Adjuvants, Immunologic/*ADMINISTRATION & DOSAGE Allergens/*ADMINISTRATION & DOSAGE Anemia, Aplastic/THERAPY Antitoxins/ADMINISTRATION & DOSAGE Bone Marrow/TRANSPLANTATION Bone Marrow Transplantation Communicable Diseases/*THERAPY Human Immunity, Maternally-Acquired Immunization Immunologic Deficiency Syndromes/THERAPY Immunosuppressive Agents/ADMINISTRATION & DOSAGE *Immunotherapy/HISTORY Neoplasms/THERAPY *Transfer Factor/ADMINISTRATION & DOSAGE/PHYSIOLOGY JOURNAL ARTICLE REVIEW

KWDadjuvants,immunologic/KWDadministration&dosageallergens/KWDadministration&dosageanemia,aplastic/therapyantitoxins/administration&dosagebonemarrow/transplantationbonemarrowtransplantationcommunicablediseases/KWDtherapyhumanimmunity,maternally-acquiredimmunizationimmunologicdeficiencysyndromes/therapyimmunosuppressiveagents/administration&dosageKWDimmunotherapy/historyneoplasms/therapyKWDtransferfactor/administration&dosage/physiologyjournalarticlereview
830228
M8320020

Copyright © 1983 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1983. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1983. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .